| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Olivier Brow. Letter to the editor on "Increased low-frequency brain responses to music after psilocybin therapy for depression". Journal of affective disorders. 2023-05-31. PMID:37257781. |
the recent publication in the journal of affective disorders titled "increased low-frequency brain responses to music after psilocybin therapy for depression" identified significant region-of-interest based effects of treatment in the task scans. |
2023-05-31 |
2023-08-14 |
Not clear |
| Olivier Brow. Letter to the editor on "Increased low-frequency brain responses to music after psilocybin therapy for depression". Journal of affective disorders. 2023-05-31. PMID:37257781. |
these concerns raise questions as to the impact of confounds, including as age and biological sex, on the reported proportion variance explained by the effects of psilocybin treatment for depression. |
2023-05-31 |
2023-08-14 |
Not clear |
| D J Heal, S L Smith, S J Belouin, J E Henningfiel. Psychedelics: Threshold of a Therapeutic Revolution. Neuropharmacology. 2023-05-29. PMID:37247807. |
the us food and drug administration (fda) has granted two breakthrough therapy designations for psilocybin in treatment resistant depression (trd) in 2018 and major depressive disorder (mdd) in 2019, as well as for mdma for the treatment of post-traumatic stress disorder (ptsd) in 2017. |
2023-05-29 |
2023-08-14 |
human |
| Kamyar Keramatian, Trisha Chakrabarty, Anais DuBois, Gayatri Saraf, Lakshmi N Yatha. New Pharmacologic Approaches to the Treatment of Bipolar Depression. Drugs. 2023-05-25. PMID:37227597. |
there are currently no adequately powered rcts of zuranolone, psilocybin or cbd in bd depression to support their use. |
2023-05-25 |
2023-08-14 |
Not clear |
| Saleha Qasim, Zaofashan Zaheer, Muhammad Youshay Jawad, Mujeeb U Sha. Neurobiological Correlates of Psilocybin Response in Depression. The primary care companion for CNS disorders. vol 25. issue 3. 2023-05-25. PMID:37230065. |
neurobiological correlates of psilocybin response in depression. |
2023-05-25 |
2023-08-14 |
Not clear |
| Brandon Weiss, David Erritzoe, Bruna Giribaldi, David J Nutt, Robin L Carhart-Harri. A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression. Journal of psychopharmacology (Oxford, England). 2023-05-01. PMID:37122239. |
a critical evaluation of qids-sr-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression. |
2023-05-01 |
2023-08-14 |
Not clear |
| Jonathan Joseph Dawood Hristova, Virtudes Pérez-Jove. Psychotherapy with Psilocybin for Depression: Systematic Review. Behavioral sciences (Basel, Switzerland). vol 13. issue 4. 2023-04-27. PMID:37102811. |
psychotherapy with psilocybin for depression: systematic review. |
2023-04-27 |
2023-08-14 |
Not clear |
| Matthew B Wall, Cynthia Lam, Natalie Ertl, Mendel Kaelen, Leor Roseman, David J Nutt, Robin L Carhart-Harri. Increased low-frequency brain responses to music after psilocybin therapy for depression. Journal of affective disorders. 2023-04-24. PMID:37094657. |
increased low-frequency brain responses to music after psilocybin therapy for depression. |
2023-04-24 |
2023-08-14 |
Not clear |
| Manish Agrawal, Ezekiel Emanuel, Brian Richards, William Richards, Kim Roddy, Paul Thamb. Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder. JAMA oncology. 2023-04-13. PMID:37052904. |
assessment of psilocybin therapy for patients with cancer and major depression disorder. |
2023-04-13 |
2023-08-14 |
Not clear |
| Franklin R Schneier, Jamie Feusner, Michael G Wheaton, Gloria J Gomez, Giselle Cornejo, Akansha Mahesh Naraindas, David J Hellerstei. Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder. Journal of psychiatric research. vol 161. 2023-04-02. PMID:37004409. |
psilocybin is a psychedelic drug with growing evidence for safety and efficacy in treatment of depression. |
2023-04-02 |
2023-08-14 |
Not clear |
| Allison Feduccia, Gabby Agin-Liebes, Collin M Price, Nicole Grinsell, Summer Paradise, David M Rabi. The need for establishing best practices and gold standards in psychedelic medicine. Journal of affective disorders. 2023-04-01. PMID:37003433. |
with the anticipated fda approval of mdma-assisted therapy for posttraumatic stress disorder in 2023 and psilocybin therapy for depression disorders soon after, now is the time for the medical community to become informed on best practices and to actively participate in developing standards of care for these new treatments. |
2023-04-01 |
2023-08-14 |
Not clear |
| Yingjie Du, Yunfeng Li, Xiangting Zhao, Yishan Yao, Bin Wang, Liming Zhang, Guyan Wan. Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity. Chinese medical journal. 2023-03-31. PMID:37000971. |
psilocybin exerts substantial therapeutic effects on depression by promoting neuroplasticity. |
2023-03-31 |
2023-08-14 |
mouse |
| Timur Zanikov, Marta Gerasymchuk, Esmaeel Ghasemi Gojani, Gregory Ian Robinson, Shima Asghari, Alyssa Groves, Lucie Haselhorst, Sanjana Nandakumar, Cora Stahl, Mackenzie Cameron, Dongping Li, Rocio Rodriguez-Juarez, Alexandra Snelling, Darryl Hudson, Anna Fiselier, Olga Kovalchuk, Igor Kovalchu. The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice. Molecules (Basel, Switzerland). vol 28. issue 6. 2023-03-29. PMID:36985596. |
recently, positive and promising clinical results of psilocybin for the treatment of depression and ptsd were reported. |
2023-03-29 |
2023-08-14 |
mouse |
| James J Rucke. Psilocybin therapy for depression. A good trip? Journal of mental health (Abingdon, England). vol 32. issue 1. 2023-03-13. PMID:36913702. |
psilocybin therapy for depression. |
2023-03-13 |
2023-08-14 |
Not clear |
| Alejandro Torrado Pacheco, Randall J Olson, Gabriela Garza, Bita Moghadda. Acute psilocybin enhances cognitive flexibility in rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2023-02-22. PMID:36807609. |
psilocybin has been shown to improve symptoms of depression and anxiety when combined with psychotherapy or other clinician-guided interventions. |
2023-02-22 |
2023-08-14 |
rat |
| Søren D Østergaard, Fredrik Hieronymu. Psilocybin for Treatment-Resistant Depression. The New England journal of medicine. vol 388. issue 8. 2023-02-22. PMID:36812443. |
psilocybin for treatment-resistant depression. |
2023-02-22 |
2023-08-14 |
Not clear |
| Bruno Roméo, Alain Dervaux, Amine Benyamin. Psilocybin for Treatment-Resistant Depression. The New England journal of medicine. vol 388. issue 8. 2023-02-22. PMID:36812444. |
psilocybin for treatment-resistant depression. |
2023-02-22 |
2023-08-14 |
Not clear |
| Aiste Lengvenyte, Emilie Olié, Philippe Courte. Psilocybin for Treatment-Resistant Depression. The New England journal of medicine. vol 388. issue 8. 2023-02-22. PMID:36812445. |
psilocybin for treatment-resistant depression. |
2023-02-22 |
2023-08-14 |
Not clear |
| Guy M Goodwin, David J Hellerstein, Allan H Youn. Psilocybin for Treatment-Resistant Depression. Reply. The New England journal of medicine. vol 388. issue 8. 2023-02-22. PMID:36812446. |
psilocybin for treatment-resistant depression. |
2023-02-22 |
2023-08-14 |
Not clear |
| Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, Merve Atli, James C Bennett, Megan Croal, Charles DeBattista, Boadie W Dunlop, David Feifel, David J Hellerstein, Muhammad Ishrat Husain, John R Kelly, Molly R Lennard-Jones, Rasmus W Licht, Lindsey Marwood, Sunil Mistry, Tomáš Páleníček, Ozlem Redjep, Dimitris Repantis, Robert A Schoevers, Batya Septimus, Hollie J Simmons, Jair C Soares, Metten Somers, Susan C Stansfield, Jessica Rose Stuart, Hannah H Tadley, Nisha K Thiara, Joyce Tsai, Mourad Wahba, Sam Williams, Rachel I Winzer, Allan H Young, Matthew B Young, Sid Zisook, Ekaterina Malievskai. Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life. Journal of affective disorders. 2023-02-05. PMID:36740140. |
single-dose psilocybin for a treatment-resistant episode of major depression: impact on patient-reported depression severity, anxiety, function, and quality of life. |
2023-02-05 |
2023-08-14 |
Not clear |